Innate immune dysfunction in acute and chronic liver disease
- PMID: 20047110
- DOI: 10.1007/s00508-009-1288-2
Innate immune dysfunction in acute and chronic liver disease
Abstract
Liver cirrhosis is a common disease causing great public-health concern because of the frequent complications requiring hospital care. Acute liver failure is also prone to several complications but is rare. One of the main complications for both acute and chronic liver diseases is infection, which regularly causes decompensation of cirrhosis, possibly leading to organ failure and death. This review focuses on innate immune function in cirrhosis, acute-on-chronic liver failure and acute liver failure. The known defects of Kupffer cells, neutrophils and monocytes are discussed, together with the pathophysiological importance of gut permeability, portal hypertension and intrinsic cellular defects, and the role of endotoxin, albumin, lipoproteins and toll-like receptors. Based on these different pathomechanisms, the available information on therapeutic strategies is presented. Antibiotic and probiotic treatment, nutritional support, artificial liver support, and experimental strategies such as inhibition of toll-like receptors and use of albumin and colony-stimulating factors are highlighted.
Similar articles
-
Infectious complications of acute and chronic liver disease.Semin Respir Crit Care Med. 2012 Feb;33(1):80-95. doi: 10.1055/s-0032-1301737. Epub 2012 Mar 23. Semin Respir Crit Care Med. 2012. PMID: 22447263 Review.
-
Innate immune response and hepatic inflammation.Semin Liver Dis. 2007 Nov;27(4):339-50. doi: 10.1055/s-2007-991511. Semin Liver Dis. 2007. PMID: 17979071 Review.
-
Immune dysfunction in cirrhosis.World J Gastroenterol. 2014 Mar 14;20(10):2564-77. doi: 10.3748/wjg.v20.i10.2564. World J Gastroenterol. 2014. PMID: 24627592 Free PMC article. Review.
-
Innate immune cells in cirrhosis.J Hepatol. 2020 Jul;73(1):186-201. doi: 10.1016/j.jhep.2020.03.027. Epub 2020 Mar 30. J Hepatol. 2020. PMID: 32240716 Review.
-
Gut-liver axis: gut microbiota in shaping hepatic innate immunity.Sci China Life Sci. 2017 Nov;60(11):1191-1196. doi: 10.1007/s11427-017-9128-3. Epub 2017 Aug 22. Sci China Life Sci. 2017. PMID: 28840534 Review.
Cited by
-
Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.PLoS One. 2016 Mar 3;11(3):e0150299. doi: 10.1371/journal.pone.0150299. eCollection 2016. PLoS One. 2016. PMID: 26938078 Free PMC article. Clinical Trial.
-
Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.Wien Klin Wochenschr. 2010 Mar;122(5-6):129-39. doi: 10.1007/s00508-010-1357-6. Wien Klin Wochenschr. 2010. PMID: 20361374 Review.
-
Anti-inflammatory and anti-fibrotic profile of fish oil emulsions used in parenteral nutrition-associated liver disease.PLoS One. 2014 Dec 12;9(12):e115404. doi: 10.1371/journal.pone.0115404. eCollection 2014. PLoS One. 2014. PMID: 25502575 Free PMC article.
-
Factors influencing severity of community-acquired pneumonia.Lung India. 2018 Jul-Aug;35(4):284-289. doi: 10.4103/lungindia.lungindia_334_17. Lung India. 2018. PMID: 29970765 Free PMC article.
-
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.Clin Infect Dis. 2011 Mar 1;52(5):674-80. doi: 10.1093/cid/ciq199. Epub 2011 Jan 19. Clin Infect Dis. 2011. PMID: 21248367 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical